ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers

May 31, 2002

A Texas Radiation Center’s Survival Move Draws M.D. Anderson Into PPM Competition

February 27, 1998

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003